Sleep Apnoea Syndrome (SAS) in Dysthymia treated with Selective Serotonin Reuptake Inhibitors (SSRIs): profile of patients with residual excessive daytime sleepiness (EDS)

V. Guevara Velázquez (Salamanca, Spain), M. Rosales Dedios (Salamanca, Spain), P. Gudiel Arriaza (León, Spain), A. Sánchez Serrano (Salamanca, Spain), J. Fernandez Sánchez (Salamanca, Spain), C. Martín Gómez (Salamanca, Spain), J. Morán Sánchez (Salamanca, Spain)

Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Session: Impact of sleep-disordered breathing in other diseases
Session type: Thematic Poster
Number: 857

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Guevara Velázquez (Salamanca, Spain), M. Rosales Dedios (Salamanca, Spain), P. Gudiel Arriaza (León, Spain), A. Sánchez Serrano (Salamanca, Spain), J. Fernandez Sánchez (Salamanca, Spain), C. Martín Gómez (Salamanca, Spain), J. Morán Sánchez (Salamanca, Spain). Sleep Apnoea Syndrome (SAS) in Dysthymia treated with Selective Serotonin Reuptake Inhibitors (SSRIs): profile of patients with residual excessive daytime sleepiness (EDS). 857

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: